FireTail Names Timo Rüppell as Vice President of Product
24.1.2023 16:30:00 EET | Business Wire | Press release
FireTail Inc., a disruptor in API security, today announced the appointment of Timo Rüppell to the executive leadership team as Vice President of Product. In conjunction with bringing Rüppell on board, FireTail also opened a new company office in Helsinki, Finland. Historically a strong cybersecurity research center, FireTail looks to expand the company’s talent pool based out of Helsinki and the Baltic States.
Rüppell brings to FireTail a wealth of experience in technology development and team leadership for early stage companies. He will work closely with co-founder and CTO Riley Priddle to define and navigate the development of FireTail’s API security platform. Previously, Rüppell served as CTO at Mapita Ltd. where he was focused on product design, including security, privacy, and compliance management. Earlier in his career, Rüppell leveraged his PhD in theoretical particle physics as a researcher for Helsinki Institute of Physics.
“FireTail is thrilled to welcome Timo to our growing team. With his background and expertise, I am confident Timo will make a lasting impact on the direction of FireTail’s products, as well as the API security market,” said Jeremy Snyder, FireTail co-founder and CEO. “It’s an exciting time for our company as we expand our presence globally, and plant roots in new cities. We look forward to all the collaboration and innovation that will take place at our new office in Helsinki.”
“After another year of watching significant breaches and security incidents at major enterprises play out in the news, the need for a new approach to solving the security threats tied to APIs has never been more clear. I look forward to working with the FireTail team to further their mission of offering simple yet effective API security that makes a positive impact and makes the internet a safer place for everyone,” added Rüppell.
FireTail will be at CloudNativeSecurityCon on Feb. 1-2, 2023 in Seattle, Washington. Visit the team in the Startup Zone to learn more about FireTail’s unique approach to solving API security threats.
The company is actively looking for startup-minded individuals with a passion for application security and cloud technologies to join the team. If you are based in Helsinki and are looking for a new opportunity, learn more about FireTail’s open roles and company culture at firetail.io/careers.
About FireTail
FireTail’s API security platform protects programmable interfaces with inline API call inspection and blocking, API security posture management, centralized API audit, and detection and response capabilities. The cloud-based solution helps organizations scale their API landscape and reduce the attack surface. FireTail makes API security as simple as import, setup, done.
FireTail is headquartered in Northern Virginia, with additional offices in Dublin, Ireland and Helsinki, Finland. To learn more about FireTail’s API security solution visit us at https://firetail.io or follow us on LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230124005251/en/
Contact information
Tori Odom
LaunchTech Communications
+1-443-752-5466
todom@golaunchtech.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IHS Towers Publishes 2025 Sustainability Report26.5.2026 13:34:00 EEST | Press release
IHS Holding Limited (NYSE: IHS) (“IHS Towers”) group, one of the largest independent owners, operators, and developers of shared communications infrastructure in the world by tower count, has today published its 2025 Sustainability Report. The report covers sustainability activities from January 1, 2025 to December 31, 2025 and demonstrates IHS Towers’ continued commitment to its stakeholders, including, but not limited to, its employees, customers, suppliers, local communities, regulators, governments and shareholders. IHS Towers’ vision is to help create a connected world, where mobile connectivity promotes continued economic growth and social development. The communications infrastructure it provides is vital to enabling that connectivity. In 2025, IHS Towers continued to advance its four-pillar sustainability strategy – focusing on ethics and governance, environment and climate change, education and economic growth, our people and communities – as detailed in this report. Sam Darwi
Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 202626.5.2026 13:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Jefferies Global Healthcare Conference on June 3, 2026 and will participate in a fireside chat at 12:45pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational CO
BeOne Medicines to Present at the Goldman Sachs 47th Annual Global Healthcare Conference26.5.2026 13:01:00 EEST | Press release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026, with a fireside chat at 10:00 a.m. EDT. The live webcast of this event can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com. An archived webcast will be available on the Company’s website. About BeOne BeOne Medicines is a global oncology company that is discovering and developing innovative treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The Company has a growing global team spanning six continents who are driven by scientific excellence and exceptional speed to reach more patients than ever before. To learn more about BeOne, please visit www.beonemedicines.com
GlobalPlatform Launches Pavona: The First Open Silicon Distribution with Production-Grade Post-Quantum Cryptography26.5.2026 13:00:00 EEST | Press release
GlobalPlatform today launched Pavona, an open-source silicon distribution that delivers production-quality, certification-ready IP components and reference top-level designs — including the first openly available post-quantum cryptography (PQC) stack for embedded silicon. The distribution includes two successfully taped-out reference designs—a standalone chip root of trust and an integrated root of trust for chiplet architectures fabricated at TSMC 3nm (N3). Pavona provides a composable framework for building secure-by-default silicon aligned with FIPS 140-3 and Common Criteria certification requirements. Twelve founding members have already committed to the initiative, spanning semiconductor manufacturers, AI companies, academic research institutions, and IP providers. The full IP repository, top-level designs, continuous integration dashboards and getting-started documentation are available today at www.pavona.org. “The world faces a rising tide of cyber insecurity, with mounting cos
Croma Skincare – Where Science Meets Skin26.5.2026 12:43:00 EEST | Press release
With Croma Skincare, Austrian family-owned company Croma Pharma translates decades of expertise in aesthetic medicine into a modern skincare line designed for everyday results. Rather than following short-lived trends, Croma focuses on scientifically proven ingredients and pharmaceutical-grade formulations that deliver visible performance while fitting seamlessly into daily routines. Building on 50 years of experience in hyaluronic acid, Croma Pharma developed this skincare range to bridge the gap between in-clinic treatments and at-home care. The result is a streamlined portfolio that supports key skin needs such as hydration, glow, balance, and protection. The formulations combine high-performance actives including niacinamide, peptides, hyaluronic acid, and plant stem cells with lightweight, fast-absorbing textures that strengthen the skin barrier and enhance overall skin health. Hero products include: THE GLOW - a 20% stabilized vitamin C serum for radiance, antioxidant protection,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
